Hydroxyzine comes as an oral tablet that’s typically taken up to four times per day. Dosage can vary depending on its use. Hydroxyzine oral tablet is a generic drug that belongs to a drug class ...

Immunocompromised people and those who are age 65 or older should get a second dose of the 2024-2025 COVID-19 vaccine, according to the latest recommendations from the Centers for Disease Control ...

Hikma will acquire parts of Xellia's US finished dosage form business and assets. According to its statement this will ...

Hikma Pharmaceuticals PLC, which is headquartered in London, plans to acquire parts of Xellia Pharmaceuticals' finished dosage form business and assets, including a commercial portfolio and ...

Low dose birth control pills may have fewer side effects compared with older, higher-dose ones, but certain groups may still have increased health risks. If they aren’t taken correctly ...

Vectura and Hikma have extended their partnership, signing an agreement to develop a generic of GlaxoSmithKline’s asthma drug, Serevent, for the US market. The product is codenamed VR730 ...

Not for use in untreated open-angle glaucoma. Reevaluate periodically. Change dose gradually. Withdrawal symptoms on abrupt cessation or dose reduction. Suicidal ideation. Psychosis. Mania.

Indian drugmaker Hikma has agreed in principle to a $150 million settlement to resolve lawsuits claiming that it contributed to the opioid crisis in the US, which could allow it to put the ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.99% to £19.98 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0. ...

Hikma Pharmaceuticals (GB:HIK) has released an update. Hikma Pharmaceuticals has decided to reappoint PricewaterhouseCoopers LLP as its external auditor starting in 2026, following a competitive ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...